| J9271 | Injection, pembrolizumab, 1 mg | 14,200 | $40 | $610.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 710 | $100 | $67.9K |
| J0897 | Injection, denosumab, 1 mg | 2,220 | $20 | $42.2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 470 | $80 | $39.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 310 | $100 | $31.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 210 | $70 | $14.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 100 | $120 | $12K |
| J0185 | Injection, aprepitant, 1 mg | 11,830 | $1 | $11.8K |
| M0010 | Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 130 | $80 | $10.3K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 380 | $20 | $8.4K |